Author:
Pluschke Gerd,Röltgen Katharina
Reference11 articles.
1. World Health Organization. Global Buruli Ulcer Initiative (2004) Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer)
2. Klis S, Stienstra Y, Phillips RO et al (2014) Long term streptomycin toxicity in the treatment of Buruli ulcer: follow-up of participants in the BURULICO drug trial. PLoS Negl Trop Dis 8:e2739. https://doi.org/10.1371/journal.pntd.0002739
3. Werf TSVD, Barogui YT, Converse PJ et al (2020) Pharmacologic management of mycobacterium ulcerans infection. Expert Rev Clin Pharmacol 13:391–401. https://doi.org/10.1080/17512433.2020.1752663
4. Scherr N, Pluschke G (2019) Buruli Ulcer. In: Neglected tropical diseases. John Wiley & Sons, Ltd, Hoboken, New Jersey, pp 325–347
5. Zhang T, Bishai WR, Grosset JH, Nuermberger EL (2010) Rapid assessment of antibacterial activity against mycobacterium ulcerans by using recombinant luminescent strains. Antimicrob Agents Chemother 54:2806–2813. https://doi.org/10.1128/AAC.00400-10
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献